Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Sells DecisionSite Platform to Microbia

NEW YORK, April 12 - Spotfire is expected to announce on Monday that privately held biotech company Microbia has bought its DecisionSite software to help its anti-infective drug-discovery research.

Microbia will integrate the Spotfire software with its Oracle-based application SCOPE, which stores biological-screening data, and with MDL Information Systems' ISIS Host, which stores the chemical properties of select compounds.

"We're building an advanced drug-discovery platform around our SCOPE system," said Kevin Durfee, Microbia's director of IT. "Spotfire is a critical piece of that system and provides a strategic advantage for our company."

Financial terms of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.